India's pharmaceutical industry is urging its government to negotiate with Washington from a “position of power” on tariffs ...

India has emerged as an increasingly significant player in the illicit fentanyl trade, according to a new intelligence report ...

By Bharath Rajeswaran (Reuters) -Indian equity benchmarks advanced on Thursday, driven by gains in heavyweight financials, ...

Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a JPMorgan ...

In an expert call, the brokerage addressed possibilities of pass-through of tariffs to consumers, and the feasibility of ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

WASHINGTON, DC – The U.S. Department of Justice has charged Indian chemical manufacturer Vasudha Pharma Chem Limited (VPC) ...

India emphasized that the weighted tariff it levies has come down from 17% in 2023 to 10.66%, following changes in duty ...

US -based pharmaceutical giant Eli Lilly recently launched its weight loss drug Mounjaro in India. Tirzepatide is the generic ...

The session highlighted existing policy support mechanisms and upcoming opportunities under the PRIP scheme aimed at ...

India is open to cutting tariffs on more than half of U.S. imports worth $23 billion in the first phase of a trade deal the ...

India has reported eight outbreaks of highly pathogenic H5N1 bird flu in farms and backyard poultry, the World Organisation ...